{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:38:53Z","timestamp":1776148733249,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":127,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.idcr.2025.e02261","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T12:09:54Z","timestamp":1746792594000},"page":"e02261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Drug analysis of a fatal case of bloodstream infection combined with urinary tract infection due to echinocandin-resistant Candida glabrata"],"prefix":"10.1016","volume":"40","author":[{"given":"Linling","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangfen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqing","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"02","key":"10.1016\/j.idcr.2025.e02261_bib1","first-page":"119","article-title":"Antifungal therapy of urinary tract infection","volume":"11","author":"Chen","year":"2011","journal-title":"Chin J Infect Chemother"},{"issue":"6","key":"10.1016\/j.idcr.2025.e02261_bib2","doi-asserted-by":"crossref","first-page":"S433","DOI":"10.1093\/cid\/cir109","article-title":"Candida urinary tract infections-epidemiology","volume":"52","author":"Sobel","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02261_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jinf.2022.08.039","article-title":"Impact of urinary tract infection-causative microorganisms on the progression to bloodstream infection: a propensity score-matched analysis","volume":"85","author":"Choi","year":"2022","journal-title":"J Infect"},{"issue":"04","key":"10.1016\/j.idcr.2025.e02261_bib4","first-page":"242","article-title":"Candida glabrata: review of epidemiology and antifungal susceptibility","volume":"11","author":"Hou","year":"2016","journal-title":"Chin J Mycol"},{"issue":"04","key":"10.1016\/j.idcr.2025.e02261_bib5","first-page":"229","article-title":"The study of the pathogenic spectrum and epidemiologic features of invasive fungal infection in China during 2008-2017","volume":"13","author":"He","year":"2018","journal-title":"Chin J Mycol"},{"issue":"10","key":"10.1016\/j.idcr.2025.e02261_bib6","first-page":"1209","article-title":"The epidemiological characteristics of Candida urinary tract infections and the efficacy of fluconazole therapy. Chinese","volume":"44","author":"Wang","year":"2019","journal-title":"J Antibiot"},{"issue":"06","key":"10.1016\/j.idcr.2025.e02261_bib7","first-page":"704","article-title":"Bacterial distribution and drug resistance of hospital urinary tract fungal infections","volume":"27","author":"Wang","year":"2015","journal-title":"Chin J Microecol"},{"issue":"4","key":"10.1016\/j.idcr.2025.e02261_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2025.e02261_bib9","series-title":"The National Antimicrobial Therapy Guidelines","first-page":"97","author":"He","year":"2023"},{"key":"10.1016\/j.idcr.2025.e02261_bib10","series-title":"The Sanford Guide to Antimicrobial Therapy","first-page":"158","author":"Gilbert","year":"2023"},{"issue":"25","key":"10.1016\/j.idcr.2025.e02261_bib11","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"issue":"9572","key":"10.1016\/j.idcr.2025.e02261_bib12","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","article-title":"Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial","volume":"369","author":"Kuse","year":"2007","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.idcr.2025.e02261_bib13","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idcr.2025.e02261_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2022.e01510","article-title":"Outcomes of caspofungin use in the treatment of Candida-related urinary tract infections, a case series","volume":"28","author":"Rkieh","year":"2022","journal-title":"IDCases"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02261_bib15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijantimicag.2016.05.010","article-title":"Urinary micafungin levels are sufficient to treat urinary tract infections caused by Candida spp","volume":"48","author":"Grau","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02261_bib16","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1086\/510432","article-title":"Caspofungin in the treatment of symptomatic candiduria","volume":"44","author":"Sobel","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"07","key":"10.1016\/j.idcr.2025.e02261_bib17","first-page":"89","article-title":"Caspofungin for the treatment of urinary tract fungal infection: a case report and literature review","volume":"16","author":"Liu","year":"2018","journal-title":"Clin Med J"},{"issue":"08","key":"10.1016\/j.idcr.2025.e02261_bib18","first-page":"80","article-title":"Caspofungin in the treatment of urinary fungal infection: a case report","volume":"20","author":"Li","year":"2022","journal-title":"Clin Med J"},{"issue":"09","key":"10.1016\/j.idcr.2025.e02261_bib19","first-page":"974","article-title":"One case of fluconazole-resistant Candida tropicalis urinary tract infection treated with caspofungin","volume":"25","author":"Chen","year":"2019","journal-title":"Chin J AIDS STD"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02261_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/jof7020108","article-title":"In vitro characterization of twenty-one antifungal combinations against echinocandin-resistant and -susceptible Candida glabrata","volume":"7","author":"Khalifa","year":"2021","journal-title":"J Fungi"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02261_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10156-008-0653-9","article-title":"In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species [published correction appears in J Infect Chemother 2009 Apr;15(2):123-4]","volume":"15","author":"Nishi","year":"2009","journal-title":"J Infect Chemother"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02261_bib22","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/AAC.02265-15","article-title":"Acquired flucytosine resistance during combination therapy with caspofungin and flucytosine for Candida glabrata Cystitis","volume":"60","author":"Charlier","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"05","key":"10.1016\/j.idcr.2025.e02261_bib23","first-page":"391","article-title":"Combined therapy for the prevention and treatment of invasive fungal infections","volume":"39","author":"Mao","year":"2018","journal-title":"World Notes Antibio"},{"issue":"01","key":"10.1016\/j.idcr.2025.e02261_bib24","first-page":"35","article-title":"Chinese consensus on the diagnosis and management of adult candidiasis","volume":"12","author":"Zhu","year":"2020","journal-title":"Chin J Front Med Sci(Electron Version)"},{"issue":"01","key":"10.1016\/j.idcr.2025.e02261_bib25","first-page":"58","article-title":"in the study of pathogenicity and drug resistance mechanisms of Candida glabrata","volume":"18","author":"Cheng","year":"2023","journal-title":"Chin J Mycol"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02261_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/jof1020277","article-title":"Candida glabrata, Friend and Foe","volume":"1","author":"Tam","year":"2015","journal-title":"J Fungi"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02261_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1590\/0074-02760150376","article-title":"First description of Candida nivariensis in Brazil: antifungal susceptibility profile and potential virulence attributes","volume":"111","author":"Figueiredo-Carvalho","year":"2016","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"Pt 9","key":"10.1016\/j.idcr.2025.e02261_bib28","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1099\/jmm.0.032037-0","article-title":"Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin","volume":"60","author":"Kuchar\u00edkov\u00e1","year":"2011","journal-title":"J Med Microbiol"},{"issue":"1-2","key":"10.1016\/j.idcr.2025.e02261_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11046-014-9727-7","article-title":"In vitro effect of amphotericin B on Candida albicans, Candida glabrata and Candida parapsilosis biofilm formation","volume":"177","author":"Pra\u017cy\u0144ska","year":"2014","journal-title":"Mycopathologia"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02261_bib30","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/08927014.2018.1472244","article-title":"Susceptibility of Candida glabrata biofilms to echinocandins: alterations in the matrix composition","volume":"34","author":"Rodrigues","year":"2018","journal-title":"Biofouling"},{"issue":"07","key":"10.1016\/j.idcr.2025.e02261_bib31","first-page":"7","article-title":"Pharmaceutical properties and clinical applications of different formulations of Amphotericin B. Clinical Medication","volume":"20","author":"Kong","year":"2022","journal-title":"Journal"},{"issue":"12","key":"10.1016\/j.idcr.2025.e02261_bib32","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations [published correction appears in Clin Infect Dis. 2014 Mar;58(5):754]","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idcr.2025.e02261_bib33","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/cid\/ciu407","article-title":"FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia","volume":"59","author":"Beyda","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02261_bib34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.01674-13","article-title":"Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates","volume":"58","author":"Castanheira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idcr.2025.e02261_bib35","article-title":"Epidemiology and echinocandin resistance mechanisms of Candida glabrata complex causing invasive infection in China: a multicenter study","author":"Hou","year":"2019","journal-title":"Chin Acad Med Sci Peking Union Med Coll"},{"issue":"9","key":"10.1016\/j.idcr.2025.e02261_bib36","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1128\/AAC.00027-12","article-title":"The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata","volume":"56","author":"Shields","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02261_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002718","article-title":"Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata","volume":"8","author":"Singh-Babak","year":"2012","journal-title":"PLoS Pathog"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250925001179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250925001179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T11:24:59Z","timestamp":1749554699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250925001179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":37,"alternative-id":["S2214250925001179"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02261","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug analysis of a fatal case of bloodstream infection combined with urinary tract infection due to echinocandin-resistant Candida glabrata","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02261"}}